California Public Employees Retirement System Sells 85,856 Shares of The Cooper Companies, Inc. $COO

California Public Employees Retirement System lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 12.7% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 589,575 shares of the medical device company’s stock after selling 85,856 shares during the period. California Public Employees Retirement System owned approximately 0.29% of Cooper Companies worth $41,954,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Sustainable Growth Advisers LP purchased a new stake in shares of Cooper Companies in the second quarter valued at $240,881,000. Franklin Resources Inc. boosted its stake in shares of Cooper Companies by 7,723.3% during the 2nd quarter. Franklin Resources Inc. now owns 1,569,512 shares of the medical device company’s stock worth $111,686,000 after purchasing an additional 1,549,450 shares during the period. Findlay Park Partners LLP grew its holdings in Cooper Companies by 312.5% during the 2nd quarter. Findlay Park Partners LLP now owns 1,815,900 shares of the medical device company’s stock valued at $129,219,000 after purchasing an additional 1,375,657 shares during the last quarter. Soundwatch Capital LLC purchased a new stake in Cooper Companies in the 2nd quarter worth about $607,000. Finally, Goldman Sachs Group Inc. raised its position in Cooper Companies by 17.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock worth $399,340,000 after purchasing an additional 686,751 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

COO opened at $80.74 on Thursday. The company has a market capitalization of $15.82 billion, a price-to-earnings ratio of 42.95, a PEG ratio of 2.24 and a beta of 1.05. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $100.47. The business’s fifty day simple moving average is $72.95 and its 200-day simple moving average is $71.67.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the firm earned $1.04 earnings per share. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its board has authorized a share repurchase program on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Morgan Stanley upped their target price on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday. JPMorgan Chase & Co. upped their price objective on Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research report on Friday, December 5th. The Goldman Sachs Group reiterated a “sell” rating and issued a $71.00 target price (up previously from $64.00) on shares of Cooper Companies in a research note on Monday. Barclays reissued an “overweight” rating and set a $91.00 target price on shares of Cooper Companies in a research note on Monday. Finally, Wells Fargo & Company raised their price target on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research note on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $90.15.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius acquired 2,000 shares of the company’s stock in a transaction dated Monday, September 29th. The shares were purchased at an average cost of $68.39 per share, for a total transaction of $136,780.00. Following the completion of the purchase, the director owned 5,777 shares in the company, valued at approximately $395,089.03. This trade represents a 52.95% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.98% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.